Trials / Completed
CompletedNCT00145457
IGF1 Generation Test
A Multicentre Study on the Capacity of the IGF-1 Stimulation Test to Predict the Growth Promoting Effect of Standard and High Doses of Genotonorm® in Prepubertal Children With Growth Hormone Deficiency.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 82 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 4 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
To assess the predictive value of the short term IGF-1 stimulation test, based on IGF-1 changes, on the 24 months growth response to 2 different doses of GH in patients with conventional GH deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sample | |
| PROCEDURE | Radiography |
Timeline
- Start date
- 2001-04-01
- Completion
- 2005-01-01
- First posted
- 2005-09-05
- Last updated
- 2007-06-06
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00145457. Inclusion in this directory is not an endorsement.